| Literature DB >> 27372450 |
Chris J D Hardy1, Charles R Marshall1, Hannah L Golden1, Camilla N Clark1, Catherine J Mummery1,2, Timothy D Griffiths3,4, Doris-Eva Bamiou5,6,4, Jason D Warren7,8.
Abstract
Hearing deficits associated with cognitive impairment have attracted much recent interest, motivated by emerging evidence that impaired hearing is a risk factor for cognitive decline. However, dementia and hearing impairment present immense challenges in their own right, and their intersection in the auditory brain remains poorly understood and difficult to assess. Here, we outline a clinically oriented, symptom-based approach to the assessment of hearing in dementias, informed by recent progress in the clinical auditory neuroscience of these diseases. We consider the significance and interpretation of hearing loss and symptoms that point to a disorder of auditory cognition in patients with dementia. We identify key auditory characteristics of some important dementias and conclude with a bedside approach to assessing and managing auditory dysfunction in dementia.Entities:
Keywords: Alzheimer’s disease; Auditory; Dementia; Frontotemporal dementia; Hearing; Lewy body disease; Progressive aphasia
Mesh:
Year: 2016 PMID: 27372450 PMCID: PMC5065893 DOI: 10.1007/s00415-016-8208-y
Source DB: PubMed Journal: J Neurol ISSN: 0340-5354 Impact factor: 4.849
An outline of core operations in auditory cognition and their clinical and neuroanatomical correlates
| Auditory cognitive operation | Clinical correlates | Neuropsychological tests | Procedurea | Neuroanatomical correlates [ |
|---|---|---|---|---|
| Feature detection | Cortical deafnessb, tinnitusc | Sound detection | Detection of any sound (e.g., tone) behaviourally/EP [ | PAC, lat HG, PT, pSTG, subcortical circuits |
| Feature analysis | Word deafnesse, dystimbriaf, amusiag | Phoneme discrimination | Discrimination of sound pairs/sequences differing in pitch, temporal or timbral characteristics [ | lat HG, pSTG/STS, aSTG, subcortical circuits |
| Scene analysis | Auditory disorientation | SSI-ICM | Identification of a sentence spoken over background message same ear [ | PT/pSTG, IPL, PFC, hippocampus, subcortical circuitsi |
| Object representation (apperceptive processing) | Auditory apperceptive agnosias, musical and verbal hallucinations | Melody discrimination | Discrimination of (unfamiliar) melodies [ | PT, pSTG/STS, IPL, aSTG |
| Object recognition (semantic processing) | Auditory associative agnosias (including phonagnosia) | Environmental sound, melody, voice recognition | Recognition of familiar sounds, tunes, voices; conventionally assessed by naming the target but can be assessed by forced-choice or matching cross-modally (e.g., sound–picture) [ | aSTG, TP, insula |
| Emotional valuation | Receptive dysprosodia, auditory anhedonia, Musicophilia | Emotion recognition | Naming, forced choice [ | MTL, insula, OFC, ACC, mesolimbic/striatal circuits |
| Working memory/attentionj | Auditory neglect/inattention | Compare sequential sounds |
| Fronto–parieto–temporal, subcortical circuits |
ACC anterior cingulate cortex, AM/FM amplitude/frequency modulation, a/pSTG anterior/posterior superior temporal gyrus, EP electrophysiological evoked potentials, IPL inferior parietal lobe, lat HG lateral Heschl’s gyrus, MBEA Montreal Battery for Evaluation of Amusia, MTL mesial temporal lobe, OFC orbitofrontal cortex, PAC primary auditory cortex, PFC prefrontal cortex, PT planum temporale, SSI-ICM synthetic sentence identification with ipsilateral competing message, STS superior temporal sulcus, TP temporal pole
aFew widely available tests or population norms are available for auditory cognition. These are mainly used in research settings, but certain instruments may be suitable for systematic clinical assessment of cognitively impaired patients (e.g., Newcastle Auditory Battery [76]; Montreal Battery for Evaluation of Amusia [77]; Queen Square Tests of Auditory Cognition for auditory object processing, voice and scene analysis [6–9, 48, 57])
bSubtotal cortical deafness often manifests as auditory agnosia
cTinnitus is mediated by distributed circuitry also including subcortical, anterior and limbic structures
dNeuroanatomical correlates vary with modulation rate
eMechanism of word deafness may be heterogeneous
fImpaired perception of timbre (that property distinguishing two sounds of identical pitch, duration and loudness, e.g., musical instrument voices)
gImpaired perception of music due to a cerebral cause
hSpeech-in-noise perception is impaired with cochlear dysfunction so interpretation of any more central deficit must be cautious [23]
iMaintaining alertness and attention
jParticularly during auditory scene analysis but relevant to auditory sequence processing more generally (auditory neglect/inattention unusual in dementia but impaired monitoring of acoustic events common)
Summary of major neurodegenerative dementias, emphasising auditory characteristics
| Disease/syndrome | Core clinical phenotype | Key auditory symptoms | Auditory cognitive processesa | Pathological neuroanatomyb | ||||
|---|---|---|---|---|---|---|---|---|
| Perc | App | Sem | Em | Wm/Att | ||||
| AD: typical [ | Episodic, topographical memory loss, parietal deficits | Difficulty tracking sound objects and information in busy acoustic environments, auditory disorientation, increased sound sensitivity |
|
|
| − |
| PCC, precuneus, temporo-parietal cortices |
|
| Visuo-perceptual, visuo-spatial, other parietal deficits |
|
| |||||
|
| Anomia, phonemic and verbal working memory deficits | − |
|
|
|
| ||
| PDD/DLBd [ | Fluctuating executive, attentional deficits, bradyphrenia, visual hallucinations, parkinsonism | Auditory hallucinations |
|
|
| Cortico–subcortical circuits | ||
| FTLD: sporadic/undefined | ||||||||
| | Socio-emotional, executive dysfunction with disinhibition, apathy, obsessionality, other behavioural abnormalities | Sound aversion, phonagnosia, altered attentive processing of auditory stimuli | − | − |
|
|
| Auditory and multimodal association cortex in ant TL, OFC, insula, ACC, striatal circuits |
| | Vocabulary loss, visual agnosia due to impaired semantic memory, behavioural changes similar to bvFTD | Musicophilia, tinnitus; phonagnosia/nonverbal sound agnosia | − |
|
|
| − | Auditory/multimodal association cortex in ant TL, OFC, insula |
| | Speech production deficits, agrammatism | Agnosia for environmental sounds, accents, word deafness |
|
|
|
|
| Peri-Sylvian networks |
| FTLD: genetic | ||||||||
| | Similar bvFTD, may have associated parkinsonism | Altered hedonic responses to sound |
|
|
| Ant TL/fronto–subcortical network | ||
| | Similar bvFTD or PNFA, may have associated motor neuron features | Auditory hallucinations | − |
|
|
| Cortico–thalamo–cerebellar network | |
| | Similar bvFTD or mixed aphasia, often prominent parietal signs | Limited information |
|
| − | − |
| Distributed intra-hemispheric networks |
| CBS/PSP [ | Executive deficits, bradyphrenia in context parkinsonism, supranuclear gaze palsy, limb dystonia – apraxia | Agnosia for environmental sounds, disordered voice emotion processing | − |
|
| Cortico–subcortical circuits, IFG | ||
| HDd [ | Executive and behavioural changes with chorea | Attentive processing of auditory stimuli |
|
| Cortico–subcortical circuits | |||
| Prion diseases [ | Usually rapid global dementia with prominent myoclonus, ataxia; wide phenotypic variation (especially genetic forms) | Occasionally tinnitus, cortical deafness, auditory hallucinations, increased sound sensitivity |
|
| Primary auditory cortex | |||
ACC anterior cingulate cortex, AD Alzheimer’s disease, ant TL anterior temporal lobe, App auditory apperception (including parsing of auditory scenes into constituent sound objects), bvFTD behavioural variant frontotemporal dementia, C9orf72 mutations in open reading frame 72 on chromosome 9, CBS/PSP corticobasal syndrome/progressive supranuclear palsy, Ep mem episodic memory for nonverbal sounds (including music), Em emotion processing from sounds (including music/prosody), FTLD frontotemporal lobar degeneration, GRN progranulin gene mutations, HD Huntington’s disease, LPA logopenic aphasia, MAPT microtubule-associated protein tau gene mutations, OFC orbitofrontal cortex, PCA posterior cortical atrophy, PCC posterior cingulate cortex, Perc early auditory perception (acoustic feature detection and analysis), PDD/DLB Parkinson's disease/Lewy body dementia, PNFA progressive nonfluent aphasia, SD semantic dementia, Sem semantic processing of sounds (including melodies), Wm/Att nonverbal auditory working memory/attention
+ deficit documented, ++ particularly severe in relation to other deficits, − deficit absent/inconsistent, blank cells indicate no adequate data available
aDefined by performance on behavioural tests
bDistribution of pathological changes in brain networks relevant to auditory deficits, as assessed using voxel-based morphometry, functional MRI and/or post mortem material
cUnderpinned by Alzheimer pathology in >80 % of cases
dAbnormalities of rhythm processing in basal ganglia and cerebellar degenerations [95, 107]
eLimited information currently for progressive aphasia presentation only
Some syndromes with peripheral or subcortical hearing impairment and dementia
| Disease | Aud | Cogn | Associated features | Diagnostic investigations |
|---|---|---|---|---|
| Inflammatory | ||||
| Antiphospholipid syndrome [ | F; C, RCa | F | Headache, seizures, chorea, myelopathy, optic neuritis, vestibulopathy | Antibody profile with compatible clinical phenotype |
| Multiple sclerosis [ | U; RCa | Fb | Diverse: vertigo, optic neuritis, various brainstem, cerebral, spinal signs | Compatible clinical and MRI features of CNS demyelination, (McDonald criteria), supported by CSF unmatched oligoclonal bands |
| Neuro-Behçet’s [ | F; RCa | Uc | Vestibulopathy, uveitis, headache, brainstem signs, hemiparesis, cerebral venous thrombosis; oral/genital ulcers | None specifically; International Study Group criteria (with pathergy test) for systemic disease |
| Neurosarcoidosis [ | U; RCa | F | Vestibulopathy, cranial nerve palsies, seizures, aseptic meningitis, myelopathy, peripheral neuropathy, pituitary dysfunction | Contrast MRI sensitive but not specific; whole body PET, biopsy involved peripheral tissue |
| Susac’s syndrome [ | T; Ca,d | T | Retinal artery occlusions; migraine, ataxia, vertigo, long tract signs | MRI (callosal ‘snowball’ lesions); retinal fluoroscein angiography (multifocal distal arteriolar occlusions) |
| Infectious | ||||
| Cryptococcal meningitis [ | U; RCa | F | Headache, papilloedema, seizures, vestibulopathy, cranial nerve palsies; more common in immunocompromised patients | CSF Cryptococcal antigen |
| Neuroborreliosis [ | U; RCe | Uf | Lymphocytic meningitis with cranial palsies, vestibulopathy | Lyme serology |
| Neurosyphilis [ | U; RCa,g | T | Chorioretinitis, Argyll Robertson pupils, vestibulopathy, cranial nerve palsies and brainstem signs, myelopathy (tabes dorsalis), brain infarcts | Treponemal serology (blood and CSF) |
| Genetic | ||||
| CADASIL [ | U; Ca | T | Migraine, stroke, psychiatric disturbance | Characteristic MRI with marked anterior temporal/external capsule white matter involvement |
| MELAS/other mitochondrial syndromes [ | T/F; C | T/F | Migraine, seizures, stroke-like episodes, ophthalmoplegia, myopathy, lactic acidosis, diabetes mellitus | Various mitochondrial DNA mutations |
| HSAN IE [ | T; C, RC?h | T | Sensory and autonomic neuropathy, optic neuropathy, narcolepsy |
|
| IBMPFD [ | U; RC? | T | Frontotemporal dementia with inclusion body myositis, Paget’s disease of bone |
|
| Niemann-Pick type C [ | F; RC | Tc | Ataxia, supranuclear gaze palsy, dystonia, psychiatric features, cataplexy, seizures, splenomegaly | Skin fibroblast studies (accumulation of unesterified cholesterol), genotyping |
| Oculo-leptomeningeal amyloidosis [ | F; RC?a | F | Seizures, stroke-like episodes, headache, ataxia, myelo-radiculopathy, subarachnoid haemorrhage, ocular amyloid | Abnormal meningeal enhancement on contrast MRI |
| Refsum disease [ | F; RC | U | Retinitis pigmentosa, anosmia, polyneuropathy | Raised plasma phytanic acid |
| Spinocerebellar ataxias: [ | F; C, RCi | F | Truncal/limb ataxia, bulbar deficits, proprioceptive impairment, neuropathy, variably prominent across group | Various mutations (most frequently, trinucleotide repeat expansions) |
| Friedreich’s ataxia [ | Cardiomyopathy, diabetes mellitus (adult onset milder) |
| ||
| SCA13 [ | Gait/limb ataxia, dysarthria, hyperreflexia, vibration sense loss |
| ||
| Wolfram’s syndrome [ | T; RC | Fj | Optic atrophy, diabetes |
|
| Other | ||||
| Prion diseases [ | U; RC | T | Rapid neurological decline, often with prominent myoclonus and ataxia | Increased cortical/basal ganglia signal on DWI/FLAIR MRI with compatible clinical phenotype; rarely prion gene mutation ( |
| Superficial siderosis [ | T; RCk | F | Cerebellar ataxia, pyramidal signs, bladder dysfunction, anosmia, anisocoria; may have history compatible with chronic subarachnoid bleeding | Haemosiderin rimming brain/spinal cord on susceptibility-weighted MRI |
CADASIL cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy, CJD Creutzfeldt-Jakob disease, DNMT1 DNA cytosine-5-methyltransferase 1 gene, DWI/FLAIR diffusion weighted/fluid-attenuated inversion recovery sequences, FXN frataxin gene, HSAN IE hereditary sensory and autonomic neuropathy with dementia and hearing loss type IE, IBMPFD inclusion body myositis with Paget’s disease of bone and frontotemporal dementia, KCNC3 potassium channel Kv3.3 gene, MELAS mitochondrial encephalopathy with lactic acidosis and stroke-like episodes, PHYH phytanoyl-CoA 2-hydroxylase gene, VCP valosin containing protein gene, WFS1 wolframin gene
The Table excludes paediatric disorders that do not also present during adult life; auditory (Aud) and cognitive (Cogn) phenotypes have been classified according to whether clinical impairments of hearing and/or cognition are: T typical of the entity (a very frequent or defining feature), F frequent (a common association), U unusual (a recognised association). The cognitive phenotype in most cases is not diagnostic, comprising variably prominent executive, subcortical and behavioural deficits and affective changes. The auditory phenotype has been classified according to the origin of hearing loss, where (often limited) information available: C cochlear, RC retrocochlear (auditory nerve and/or brainstem pathways)
aMay be sudden
bGenerally more significant in progressive forms
cMay have prominent neuropsychiatric changes
dLow-to-mid-frequency loss characteristic
eMay have persistent post-treatment altered hearing (e.g., loudness intolerance)
fSubjective cognitive symptoms frequent
gMénière’s-like presentations may occur
hMid-frequency loss
iAuditory brainstem pathway involvement appears more functionally significant than more peripheral involvement and may disrupt temporal processing leading to deficits of spatial and speech perception (frequency of impairment varies with mutation)
jMay be more prominent in later disease
kPrimary cochlear damage may also contribute
Fig. 1Neuroanatomical signatures of disordered auditory cognition in dementias. The cutaway brain schematic (centre) shows cerebral networks that mediate key components of auditory cognition, coded I to VI (below) and based on clinical and normal functional neuroanatomical evidence (see Tables 1, 2); ‘features’ here subsumes acoustic feature detection and analysis, ‘objects’ corresponds to auditory apperceptive processing and ‘recognition’ corresponds to auditory semantic processing. The left cerebral hemisphere is projected forward in the schematic; however, neuroanatomical correlates of auditory cognition are bi-hemispherically distributed, principally, including: a amygdala, ACC anterior cingulate cortex, ATL anterior temporal lobe, BG basal ganglia, h hippocampus, HG Heschl’s gyrus (containing primary auditory cortex), IFG inferior frontal gyrus/frontal operculum, ins insula, OFC orbitofrontal cortex, PFC prefrontal cortex, PMC posterior medial cortex (posterior cingulate, precuneus), STG superior temporal gyrus/superior temporal sulcus/planum temporale, TPJ temporo–parietal junction. Side panels show characteristic profiles of regional cerebral atrophy (coronal MRI sections) and auditory cognitive functions chiefly affected in selected dementias (see also Table 2): typical Alzheimer’s disease (AD), bilateral symmetrical mesial temporal and parietal lobe atrophy; behavioural variant frontotemporal dementia (bvFTD), asymmetric (predominantly right-sided) frontal and temporal lobe atrophy; logopenic aphasia (LPA) variant of Alzheimer’s disease, predominantly left-sided temporo-parietal atrophy; microtubule-associated protein tau (MAPT) gene mutations, bilateral (predominantly antero-mesial) temporal lobe atrophy; progressive nonfluent aphasia (PNFA), predominantly left-sided peri-Sylvian atrophy; and semantic dementia (SD), asymmetric (predominantly left-sided) anterior temporal lobe atrophy
Taking the auditory history in patients with cognitive impairment
| Domain | Question | Key process probed | Significance |
|---|---|---|---|
| Background | Previous occupation? | Previous cognitive/auditory function, noise exposure | Correct interpretation of hearing tests |
| Previous level of musical training and interest, early language development and education? | Prior auditory expertise | Correct interpretation of hearing tests | |
| Course | When was hearing impairment first noticed? | Duration of impairment (relative to cognitive decline) | Nature of underlying disease process |
| Has this deteriorated, fluctuated or improved since onset? | Tempo of impairment | Nature of underlying disease process | |
| Symptoms | |||
| Sound detection | Is there a lack of reaction to sounds? | Impaired sound detection | May signify deafness (any cause) |
| Is there a tendency to turn up the volume of radio or TV or to ask people to speak louder? | Impaired sound detection | May signify deafness (any cause) | |
| Is there a complaint that increasing volume makes sounds suddenly seem too loud? | Impaired sound detection | May signify cochlear pathology (‘loudness recruitment’) | |
| Abnormal auditory perception: deficient | Is there particular difficulty following conversations in background noise or over a noisy telephone line? | Auditory scene analysis | May signify a cerebral disorder (e.g., Alzheimer’s disease) in absence of significant hearing loss |
| Is there difficulty locating sounds (e.g., an alarm or mobile, a person speaking in same the room)? | Auditory scene analysis | May signify a cerebral disorder in absence of significant hearing loss | |
| Is there particular difficulty understanding speech versus other sounds? | Feature analysis | May signify word deafness | |
| Is there more difficulty understanding less familiar accents? | Apperceptive processing | May signify a cerebral disorder in absence of significant hearing loss | |
| Is there more difficulty understanding a person’s tone of voice (e.g., angry or upset)? | Apperceptive and emotional processing | May signify a frontotemporal dementia in appropriate context | |
| Has there been any problem recognising familiar voices, music or other sounds? | Semantic processing | May signify auditory agnosia or semantic dementia, in appropriate context | |
| Abnormal auditory perception: excessive | Is there a persistent complaint of buzzing or ringing in the ears? | Tinnitus | May be peripheral or central in origin |
| Are other sounds ever heard when no sounds are present? | Formed hallucinations | May signify Lewy body disease, in appropriate context | |
| Abnormal auditory behaviour | Is there intolerance to moderately loud sounds or particular sounds? | Hyperacusis | May signify a frontotemporal dementia in appropriate context |
| Has there been any change in liking for or interest in music or other sounds? | Auditory hedonic processing | May signify a frontotemporal dementia in appropriate context | |
In all cases, a corroborating history should be sought from the patient’s caregiver or other advocate. See also Tables 1, 2, 3; Fig. 2
Fig. 2A clinical approach to the patient presenting with cognitive decline and altered hearing. Our approach is based on initial thorough bedside history taking and examination to identify key auditory symptoms (see also Table 4) supplemented by investigations to characterise the nature of the patient’s hearing and cognitive deficits. As clinical symptoms are rarely specific and disorders at different levels of the auditory processing hierarchy frequently coexist, we recommend a core hearing assessment battery in all cases, corroborated by general neuropsychological assessment and brain MRI. Together, these assessments often allow the patient’s hearing deficit to be localised predominantly to the cochlea or ascending auditory pathways (unfilled oblongs) or to cerebral circuitry (black filled oblongs) and direct further more specific assessment for the diagnoses listed in Tables 2, 3. Other patients will have auditory deficits that are more difficult to localise or may have mixed deficits (grey oblongs); speech-in-noise perception is a useful index of real world hearing impairment but needs care in interpretation as this can be affected by pathology at different levels of the auditory system. Management in all cases should involve consideration of environmental and behavioural modification strategies that optimise the patient’s residual hearing function (see text) and involvement of multidisciplinary services to assess their needs and plan appropriate care delivery; we have a low threshold for a trial of hearing aids or other assistive listening devices if there is the possibility of a contributing peripheral hearing loss and in patients with more complex or central auditory deficits, onward referral to a specialist cognitive or auditory clinic may be helpful. Asterisk particularly in younger patients or where there are associated neurological or systemic features; double asterisk more specialised tests of central hearing functions if available may be useful in defining the phenotype of an auditory cortical disorder, particularly where all standard tests of hearing are unremarkable; ABR auditory brainstem evoked responses, AHQ auditory handicap questionnaire, ALD assistive listening device, behav behavioural, env environmental, DLT dichotic listening test, GiN gap-in-noise perception, HA hearing aid, MBEA Montreal Battery for Evaluation of Amusia, MRI brain magnetic resonance imaging, NAB Newcastle Auditory Battery, neuropsych neuropsychology, OAE otoacoustic emissions, PTA pure tone audiometry, SiN speech-in-noise perception